Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Confluent (CFLT) Gains from Sales and Divestitures (2021 - 2025)

Confluent (CFLT) has disclosed Gains from Sales and Divestitures for 5 consecutive years, with $3.7 million as the latest value for Q1 2025.

  • For the quarter ending Q1 2025, Gains from Sales and Divestitures rose 30.69% year-over-year to $3.7 million, compared with a TTM value of $3.7 million through Mar 2025, up 30.69%, and an annual FY2024 reading of $12.2 million, up 28.99% over the prior year.
  • Gains from Sales and Divestitures was $3.7 million for Q1 2025 at Confluent, down from $12.2 million in the prior quarter.
  • Across five years, Gains from Sales and Divestitures topped out at $12.2 million in Q4 2024 and bottomed at $15250.0 in Q2 2021.
  • Average Gains from Sales and Divestitures over 5 years is $4.1 million, with a median of $3.3 million recorded in 2024.
  • The sharpest move saw Gains from Sales and Divestitures surged 8502.42% in 2022, then grew 28.99% in 2024.
  • Year by year, Gains from Sales and Divestitures stood at $648494.0 in 2021, then skyrocketed by 540.72% to $4.2 million in 2022, then soared by 128.3% to $9.5 million in 2023, then increased by 28.99% to $12.2 million in 2024, then crashed by 69.89% to $3.7 million in 2025.
  • Business Quant data shows Gains from Sales and Divestitures for CFLT at $3.7 million in Q1 2025, $12.2 million in Q4 2024, and $9.1 million in Q3 2024.